.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Mary's Medicinals concentrated 76.13% of May 2026 sales in Topical with a -28.64% year-over-year change and a 3.14% month-over-month lift, while Tincture & Sublingual held 23.87% share with a -10.01% year-over-year decline and a 12.52% month-over-month increase. Average price rose 10.30% year over year to $27.18, with Topical at an average price of 26.79 and Tincture & Sublingual at 28.52, indicating pricing power even as total brand sales fell -25.03% year over year and -30.72% over 24 months; this mix suggests the category drag is concentrated in Topical despite short-term momentum, while Tincture & Sublingual is the relative stabilizer.
With Topical accounting for over three-quarters of volume and ranked 1 in Missouri for that category, the -28.64% Topical year-over-year drop versus a 12.52% month-over-month rise in Tincture & Sublingual implies overexposure to a contracting anchor offset by a smaller but quicker-recovering adjunct. The 3.14% Topical month-over-month uptick alongside a 10.30% brand-wide price increase signals elasticity tolerance, yet the -25.03% brand year-over-year trend indicates that mix-weighted recovery requires accelerating share in Tincture & Sublingual and converting Topical rank strength into sustained sell-through.
Competitive Landscape
Mary's Medicinals sits at rank #2 in CA Topical in May 2026, unchanged from #2 year over year, and it has held #2 for three consecutive months while also marking its peak at #2 in May 2026; this flat rank contrasts with Papa & Barkley holding #1 despite a -10.9% year-over-year sales change and Liquid Flower rising from #6 to #4 with a 62.2% year-over-year increase. Meanwhile, Buddies remains anchored at #3 with 33.0% year-over-year growth while Sweet ReLeaf (CA) stays at #5 with a -5.2% decline, indicating Mary's Medicinals is defending share against a weakening category leader and faster-growing mid-pack climbers; the pattern implies that holding #2 without upward movement signals a risk of being leapfrogged by accelerating competitors unless relative velocity improves.
Notable Products
Indica Relax Transdermal Patch (20mg) delivered the headline move in May 2026 with a 79.7% month-over-month surge and a climb to rank 2, while CBD/THC 1:1 Vanilla Lavender Transdermal Relax Cream (1000mg CBD, 1000mg THC, 2oz, 59.1ml) fell 12.7% to rank 8. CBD/THC 1:1 Large Colling Action Relief Muscle Freeze (1000mg CBD, 1000mg THC, 3oz) contracted 28.5% and slid to rank 10, whereas CBD/THC/CBN 2:3:1 Formula Transdermal Patch (10mg CBD, 15mg THC, 5mg CBN) inched up 7.3% to hold rank 1. With eight of the top ten being Topical SKUs and two Tincture & Sublingual entries sitting at ranks 7 and 9, the pattern implies a product mix consolidating around transdermal formats with targeted mood-state patches offsetting softness in larger-format creams.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
